CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-31 | Adcock Richard CEO & President | Option exercise · Restricted Stock Units | −34,483 | 51,731 | ||
| 2025-12-12 | Wendel Bruce Director | Grant or award · Stock Option (right to buy) | +146,020 | 146,020 | ||
| 2025-06-18 | Selecky Christobel Director | Grant or award · Stock Option (right to buy) | +162,786 | 162,786 | ||
| 2025-06-18 | Cohen Cheryl Director | Grant or award · Stock Option (right to buy) | +162,786 | 162,786 | ||
| 2025-06-18 | BLASZYK MICHAEL D Director | Grant or award · Stock Option (right to buy) | +162,786 | 162,786 | ||
| 2025-06-18 | MAXWELL LINDA Director | Grant or award · Stock Option (right to buy) | +162,786 | 162,786 | ||
| 2025-06-18 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +162,786 | 162,786 | ||
| 2025-02-22 | LAUER REGAN J Chief Accounting Officer | Option exercise | +4,065 | 111,927 | ||
| 2025-02-22 | LAUER REGAN J Chief Accounting Officer | Shares withheld for taxes | −1,669 | $3.42 | $6K | 110,258 |
| 2025-02-22 | LAUER REGAN J Chief Accounting Officer | Option exercise · Restricted Stock Units | −4,065 | 8,130 | ||
| 2025-02-22 | SOON-SHIONG PATRICK See remarks | Option exercise | +114,329 | 29,588,261 | ||
| 2025-02-22 | SOON-SHIONG PATRICK See remarks | Shares withheld for taxes | −42,071 | $3.42 | $144K | 29,546,190 |
| 2025-02-22 | SOON-SHIONG PATRICK See remarks | Option exercise · Restricted Stock Units | −114,329 | 228,658 | ||
| 2025-02-22 | Sachs David C. Chief Financial Officer | Option exercise | +40,650 | 241,480 | ||
| 2025-02-22 | Sachs David C. Chief Financial Officer | Shares withheld for taxes | −15,860 | $3.42 | $54K | 225,620 |
| 2025-02-22 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −40,650 | 81,301 | ||
| 2025-02-22 | Adcock Richard CEO & President | Option exercise | +152,439 | 412,585 | ||
| 2025-02-22 | Adcock Richard CEO & President | Shares withheld for taxes | −78,167 | $3.42 | $267K | 334,418 |
| 2025-02-22 | Adcock Richard CEO & President | Option exercise · Restricted Stock Units | −152,439 | 304,878 | ||
| 2025-02-22 | Simon Barry J. Director | Option exercise | +15,243 | 3,249,024 |
Page 5 of 12 · 226 trades